当前位置: 首页 > 期刊 > 《右江医学》 > 2025年第7期
编号:2393965
甲苯磺酸瑞马唑仑联合瑞芬太尼用于ICU气管插管患者的镇静效果和安全性分析
http://www.100md.com 2025年8月31日 右江医学 2025年第7期
     中图分类号:R614 文献标志码:A DOI:10.3969/j. issn. 1003-1383.2025.07.005

    【Abstract】ObjectiveToanalyze thesedative efectand safetyofrimazolam tosylate combined with remifentanil in ICU patientsundergoing trachealintubation.MethodsAtotalof1OOpatientswho wereadmitedtotheICUoftheFifthAffliatedHospitalof ZhengzhouUniversityandunderwenttrachealintubationfromJanuary2O23toFebruary2O24wereselected. According to random number table,thepatientswere divided into propofol group(group P)and rimazolam tosylate group (groupR),with 5O patients ineach group.Both groups werecombinedwithremifentanil(administeredasan intravenous bolus of 0.5μg/kg ,followed by a maintenance infusion of 4-9μg?kg-1?min-1 ).The positive responses to tracheal intubation wererecordedforboth groupsof patients,andthetimerequiredtoreachthesedationtargetandthemodified observer'sasessmentofalertness/sedation(MOAA/S)sedationscoreat2minutesafterdrugadministrationwerealsorecorded for both groups.The cardiovascular and respiratory parameters(heart rate[HR],meanarterial pressure [MAP]. respiratory rate[RR],and arterial oxygen saturation ?SpO2? )were recorded at the following time points:before anesthesia (TO) ......

您现在查看是摘要页,全文长 18266 字符